Discharge prescriptions issued by mental health NHS hospitals are affected by high levels of prescribing, clerical and communication errors. Important targets for intervention have been identified to improve medication safety problems at care transfer.
Objective
To undertake a systematic review and meta-analysis of pharmacological interventions for depression in people with traumatic brain injury.
Method
Searches were undertaken for randomised controlled trials of pharmacological interventions in people with depression and traumatic brain injury. Searches were carried out as per our protocol and studies that fulfilled our inclusion criteria were included in the meta-analysis.
Results
Four studies were identified that fulfilled our inclusion criteria. Sertraline, desipramine, methylphenidate and modafinil were investigated in these studies. There were 72 participants in total in the intervention arm and 57 participants in the placebo arm. Meta-analysis showed favourable results for sertraline, desipramine and methylphenidate on outcomes measures for depressive symptoms. Only results for methylphenidate were statistically significant. Sertraline, methylphenidate and modafinil showed favourable results on quality of life indicators but results were not statistically significant. Sertraline showed favourable results on outcome measures for anxiety symptoms but results were not statistically significant.
Conclusion
Some pharmacological interventions appear to improve depressive symptoms, anxiety symptoms and quality of life in people with depression and traumatic brain injury. However, the evidence is limited. There is a paucity of evidence for the effectiveness of other pharmacological interventions used in depression in this particular patient group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.